BOSTON SCIENTIFIC CORP — Director's Dealing 2019

Dec 2, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2019-11-27

Reporting Person: Nanavaty Maulik (SVP & Pres, Neuromodulation)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-27	Common Stock	M	20552.0000	$17.2600	Acquired	275746.0000	Direct
2019-11-27	Common Stock	S	20552.0000	$43.2718	Disposed	255194.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-27	Stock Option (Right to Buy)	$17.2600	M	20552.0000	Disposed	2026-02-22	Common Stock (20552.0000)	Direct

Footnotes

F1: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.

F2: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.27 to $43.28, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.